Indian Immunologicals working on bi-valent human monoclonal antibody for rabies
Indian Immunologicals Ltd is working on a bi-valent monoclonal antibody for rabies with backing from the National Biopharma Mission and BIRAC. This innovation aims to revolutionize rabies management, particularly in India, which sees 36% of global rabies deaths. The company also claims to be the largest manufacturer of rabies vaccines worldwide.